knowledge -WSS

knowledge

author：comprehensive 2025-09-28 23:11:42 - browse：543

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

WSS

Young boy dies in trial for Pfizer Duchenne gene therapy

Florida Supreme Court upholds state's abortion ban

WHO may add ‘noma' to its list of neglected tropical diseases

Gut bacteria may contribute to kidney autoimmunity, study finds

UnitedHealth, in a surprise, takes aim at Steward’s physician group

The pink breast cancer awareness ribbon needs a redesign

entertainment

knowledge

hotspot

Walensky prepares to leave CDC — and Congress — behind

Mass General Brigham physicians react to latest merger step

Duchenne breakthrough therapy leaves behind pioneering families

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Continuity nursing helped my family in our darkest PICU moments

Bird flu in dairy cattle: New measures to control spread to humans

Dobbs anniversary: the lost opportunity of abortion as health care

Scientists uncover potential path to treating deadly childhood tumor

Moonlake's readout produced a cash windfall. Risks remain

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

focus

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: What happened with Sarepta's Duchenne data

Readout Newsletter: XBI biotech index, Akero Therapeutics

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Maker of FluMist seeks to allow at

knowledge

hotspot

focus

leisure time